Freeline Therapeutics Holdings Price Prediction
As of today the value of rsi of Freeline Therapeutics' share price is below 20 . This usually indicates that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.
The successful prediction of Freeline Therapeutics' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Freeline Therapeutics Holdings, which may create opportunities for some arbitrage if properly timed.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
Momentum 0
Sell Peaked
Oversold | Overbought |
Using Freeline Therapeutics hype-based prediction, you can estimate the value of Freeline Therapeutics Holdings from the perspective of Freeline Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Freeline Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Freeline because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Freeline Therapeutics after-hype prediction price | USD 0.0 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Freeline |
| Symbol | FRLN |
| Name | Freeline Therapeutics Holdings |
| Type | Stock |
| Country | United States |
| Exchange | NASDAQ |
Hype Analysis is not found for Freeline Therapeutics Holdings at this timeWe are unable to locate Freeline Therapeutics Holdings hype analysis at this time. If you believe the equity you are trying to look up is valid, please let us know, and we will check it out.Hype Analysis
Prediction analysis is currently not available
Other Suggestions
| FR | First Industrial Realty | Company |
| FRT-PC | Federal Realty Investment | Company |
| FRA | Blackrock Floating Rate | Fund |
| FRI | First Trust SP | ETF |
| FRM | FRM | Cryptocurrency |
Thematic Opportunities
Explore Investment Opportunities
Did you try this?
Run Portfolio Analyzer Now
Portfolio AnalyzerPortfolio analysis module that provides access to portfolio diagnostics and optimization engine |
| All Next | Launch Module |
Freeline Therapeutics Additional Predictive Modules
Most predictive techniques to examine Freeline price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Freeline using various technical indicators. When you analyze Freeline charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Story Coverage note for Freeline Therapeutics
The number of cover stories for Freeline Therapeutics depends on current market conditions and Freeline Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Freeline Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Freeline Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Freeline Therapeutics Short Properties
Freeline Therapeutics' future price predictability will typically decrease when Freeline Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Freeline Therapeutics Holdings often depends not only on the future outlook of the potential Freeline Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Freeline Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 4 M | |
| Cash And Short Term Investments | 47.3 M |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in Freeline Stock
If you are still planning to invest in Freeline Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Freeline Therapeutics' history and understand the potential risks before investing.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |